Anthropometry (1)
- BMI - Baseline body mass index (BMI) (phv00437305.v2.p1)
Demographics (4)
- AGE - Subject age at Randomization (phv00437304.v1.p1)
- COLLECTION_AGE - Age sample was collected (phv00437315.v1.p1)
- GENDER - Reported gender (phv00437302.v1.p1)
- SEX - Biological sex (phv00437296.v1.p1)
Diet (1)
- SELENIUM - Baseline plasma selenium concentrations (phv00437308.v2.p1)
Disease Events (6)
- ADVANCEDFU - Metachronous adenoma with advanced features (phv00496043.v1.p1)
- FAMHXCRC - Family history of colorectal cancer (phv00496039.v1.p1)
- HIST_POLYPS - History of polyps prior to the qualifying colonoscopy for the trial (phv00437307.v1.p1)
- HXCANCER - Subject history of cancer (phv00496040.v1.p1)
- MULTADNMFU - Multiple metachronous adenoma at follow up (phv00496042.v1.p1)
- RECURFU - Metachronous adenoma at followup (phv00496041.v1.p1)
Race and Ethnicity (2)
- HISPANIC - Self-reported Hispanic ethnicity (phv00437300.v1.p1)
- RACE - Self-reported race (phv00437301.v1.p1)
Other (13)
- ANALYTE_TYPE - Analyte Type (phv00437313.v1.p1)
- ARMS - Randmaization Group (phv00437303.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00437312.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00437295.v1.p1)
- IS_TUMOR - Tumor status (phv00437314.v1.p1)
- PILL_PER_DAY - Average number of pills taken per day (phv00437310.v2.p1)
- SAMPLE_ID - Sample ID (phv00437311.v1.p1)
- SAMPLE_ID - Sample ID (phv00437298.v1.p1)
- SE_FU - Plasma selenium concenration at 1 year follow-up (phv00437309.v2.p1)
- SUBJECT_ID - Subject ID (phv00437299.v1.p1)
- SUBJECT_ID - Subject ID (phv00437294.v1.p1)
- SUBJECT_ID - Subject ID (phv00437297.v1.p1)
- WHR - Waist to Hip Ratio (phv00437306.v2.p1)